- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genocea Biosciences Inc (GNCAQ)
Genocea Biosciences Inc stock price live, this page displays OTC GNCAQ stock exchange data. View the GNCAQ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genocea Biosciences Inc real time stock price chart below.
What Is the Genocea Biosciences Inc Stock Price Today?
The Genocea Biosciences Inc stock price today is 0.000100.
What Is the Stock Symbol for Genocea Biosciences Inc?
The stock symbol for Genocea Biosciences Inc is "GNCAQ."
What Stock Exchange Does Genocea Biosciences Inc Trade On?
Genocea Biosciences Inc is listed and trades on the OTC Markets stock exchange.
Is Genocea Biosciences Inc a Good Stock to Buy?
Determining whether Genocea Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNCAQ quote. (ISIN: US3724274010)
What Is the Genocea Biosciences Inc Stock Price Today?
The Genocea Biosciences Inc stock price today is 0.000100.
What Is the Stock Symbol for Genocea Biosciences Inc?
The stock symbol for Genocea Biosciences Inc is "GNCAQ."
What Stock Exchange Does Genocea Biosciences Inc Trade On?
Genocea Biosciences Inc is listed and trades on the OTC Markets stock exchange.
Is Genocea Biosciences Inc a Good Stock to Buy?
Determining whether Genocea Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNCAQ quote. (ISIN: US3724274010)
OTC Markets
Currency in USD
0.000100
+0.000099(+9,900.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.000100
0.000100
52 wk Range
0.000001
0.008800
GNCAQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0001000.000100
52 wk Range
0.0000010.008800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GNCAQ Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Earnings
Latest Release
Mar 12, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare GNCAQ to Peers and Sector
Metrics to compare | GNCAQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGNCAQPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −0.6x | −0.5x | |
PEG Ratio | 0.00 | 0.04 | 0.00 | |
Price/Book | 0.0x | 2.0x | 2.6x | |
Price / LTM Sales | 0.0x | 6.8x | 3.1x | |
Upside (Analyst Target) | 0.0% | 101.4% | 54.9% | |
Fair Value Upside | Unlock | −4.7% | 7.1% | Unlock |
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts. The plan was later approved as Chapter 11 liquidation on May 11, 2023.
People Also Watch
FAQ
What Is the Genocea Bio (GNCAQ) Stock Price Today?
The Genocea Bio stock price today is 0.000100 USD.
What Stock Exchange Does Genocea Bio Trade On?
Genocea Bio is listed and trades on the OTC Markets.
What Is the Stock Symbol for Genocea Bio?
The stock symbol for Genocea Bio is "GNCAQ."
What Is the Genocea Bio Market Cap?
As of today, Genocea Bio market cap is 5.880000K USD.
What Is Genocea Bio's Earnings Per Share (TTM)?
The Genocea Bio EPS (TTM) is -0.532700.
When Is the Next Genocea Bio Earnings Date?
Genocea Bio will release its next earnings report on May 28, 2026.
From a Technical Analysis Perspective, Is GNCAQ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Genocea Bio Stock Split?
Genocea Bio has split 1 times.
How Many Employees Does Genocea Bio Have?
Genocea Bio has 74 employees.
What is the current trading status of Genocea Bio (GNCAQ)?
As of May 28, 2026, Genocea Bio (GNCAQ) is trading at a price of 0.000100 USD, with a previous close of 0.000100 USD. The stock has fluctuated within a day range of 0.000100 USD to 0.000100 USD, while its 52-week range spans from 0.000001 USD to 0.008800 USD.
What Is the GNCAQ After Hours Price?
GNCAQ's last after hours stock price is 0.000001 USD, the stock has decreased by -0.000099, or -99.000000%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.